T2Bacteria Panel Wins CMS Approval For New Tech Add-On Payment

The US Medicare agency approved a new technology add-on payment (NTAP) for T2 Biosystems’ blood test, the T2Bacteria panel, for the fiscal year that will begin on 1 October.

Array of blood samples for microscopy and biopsy tissue on blue gradient background

More from Policy & Regulation

More from Medtech Insight